Your browser doesn't support javascript.
loading
Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study.
Schjesvold, Fredrik H; Ludwig, Heinz; Delimpasi, Sossana; Robak, Pawel; Coriu, Daniel; Tomczak, Waldemar; Pour, Ludek; Spicka, Ivan; Dimopoulos, Meletios-Athanasios; Masszi, Tamas; Chernova, Natalia G; Sandberg, Anna; Thuresson, Marcus; Norin, Stefan; Bakker, Nicolaas A; Mateos, Maria-Victoria; Richardson, Paul G; Sonneveld, Pieter.
Afiliação
  • Schjesvold FH; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway. fredrikschjesvold@gmail.com.
  • Ludwig H; Department of Medicine I, Center for Medical Oncology and Hematology with Outpatient Department and Palliative Care, Wilhelminen Cancer Research Institute, Vienna.
  • Delimpasi S; Bone Marrow Transplantation Unit and Department of Hematology, Evangelismos Hospital, Athens, Greece.
  • Robak P; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Coriu D; University of Medicine and Pharmacy "Carol Davila", Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
  • Tomczak W; Department of Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Babak Myeloma Group, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Spicka I; 1st Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic.
  • Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Masszi T; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.
  • Chernova NG; National Research Center for Haematology, Moscow, Russia.
  • Sandberg A; Oncopeptides AB, Stockholm, Sweden.
  • Thuresson M; Oncopeptides AB, Stockholm, Sweden.
  • Norin S; Oncopeptides AB, Stockholm, Sweden.
  • Bakker NA; Oncopeptides AB, Stockholm, Sweden.
  • Mateos MV; Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain.
  • Richardson PG; Dana-Farber Cancer Institute, Boston, MA.
  • Sonneveld P; Erasmus MC Cancer Institute, Rotterdam.
Haematologica ; 109(7): 2331-2336, 2024 07 01.
Article em En | MEDLINE | ID: mdl-38426292
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Noruega